These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16234760)

  • 1. [National cohort of patients with emphysema and alpha-1 antitrypsin deficiency].
    Thabut G
    Rev Mal Respir; 2005 Dec; 22(6 Pt 1):1053-7. PubMed ID: 16234760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emphysema and bronchiectasis secondary to alpha-1 antitrypsin deficiency.
    Fahim A; Wilmot R; Hart SP
    J Coll Physicians Surg Pak; 2013 Mar; 23(3):224-5. PubMed ID: 23458051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Often overlooked alpha 1-antitrypsin deficiency emphysema. Early diagnosis could improve the prognosis].
    MMW Fortschr Med; 2005 May; 147(18):50-1. PubMed ID: 15934592
    [No Abstract]   [Full Text] [Related]  

  • 4. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
    Stockley RA; Edgar RG; Pillai A; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1745-56. PubMed ID: 27536086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of mortality in alpha1-antitrypsin deficiency.
    Dawkins PA; Dowson LJ; Guest PJ; Stockley RA
    Thorax; 2003 Dec; 58(12):1020-6. PubMed ID: 14645964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of the patients included in the French cohort of patients with emphysema caused by alpha-1 antitrypsin deficiency].
    Thabut G; Mornex JF; Cuvelier A; Padrazzi B; Pison C; Neukirch F; Lafitte JJ; Boczkowski J; Balduyck M; Muir JF; Carles P; Fournier M
    Rev Mal Respir; 2008 Nov; 25(9):1115-22. PubMed ID: 19106908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in patients with alpha-1 antitrypsin deficiency: the French experience.
    Gauvain C; Mornex JF; Pison C; Cuvelier A; Balduyck M; Pujazon MC; Fournier M; AitIlalne B; Thabut G
    COPD; 2015 May; 12 Suppl 1():46-51. PubMed ID: 25938292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.
    Sorrells S; Camprubi S; Griffin R; Chen J; Ayguasanosa J
    Respir Med; 2015 Apr; 109(4):490-9. PubMed ID: 25727857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the BODE index in patients with α1-antitrypsin deficiency-related COPD.
    Thabut G; Mornex JF; Pison C; Cuvelier A; Balduyck M; Pujazon MC; Fournier M; AitIlalne B; Porcher R
    Eur Respir J; 2014 Jul; 44(1):78-86. PubMed ID: 24525449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
    Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
    Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of smoke exposure on the clinical phenotype of alpha-1 antitrypsin deficiency in Ireland: exploiting a national registry to understand a rare disease.
    O'Brien ME; Pennycooke K; Carroll TP; Shum J; Fee LT; O'Connor C; Logan PM; Reeves EP; McElvaney NG
    COPD; 2015 May; 12 Suppl 1():2-9. PubMed ID: 25938284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency.
    Piitulainen E; Tanash HA
    COPD; 2015 May; 12 Suppl 1():36-41. PubMed ID: 25938290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.
    Strange C; Senior RM; Sciurba F; O'Neal S; Morris A; Wisniewski SR; Bowler R; Hochheiser HS; Becich MJ; Zhang Y; Leader JK; Methé BA; Kaminski N; Sandhaus RA;
    Ann Am Thorac Soc; 2015 Oct; 12(10):1551-60. PubMed ID: 26153726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of emphysema distribution in smokers and patients with alpha1-antitrypsin deficiency.
    Stavngaard T; Shaker SB; Dirksen A
    Respir Med; 2006 Jan; 100(1):94-100. PubMed ID: 15882941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The national alpha-1 antitrypsin deficiency registry in Poland.
    Chorostowska-Wynimko J; Struniawski R; Sliwinski P; Wajda B; Czajkowska-Malinowska M
    COPD; 2015 May; 12 Suppl 1():22-6. PubMed ID: 25938287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Alpha-1 Antitrypsin Deficiency.
    Strange C; Beiko T
    Semin Respir Crit Care Med; 2015 Aug; 36(4):470-7. PubMed ID: 26238635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-1 Antitrypsin Deficiency: Phenotypes and Quality of Life.
    Stockley RA
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S332-5. PubMed ID: 27564669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nine controversial questions about augmentation therapy for alpha-1 antitrypsin deficiency: a viewpoint.
    Miravitlles M; Anzueto A; Barrecheguren M
    Eur Respir Rev; 2023 Dec; 32(170):. PubMed ID: 38056890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lack of effect of substitution therapy of alpha1-antitrypsin deficiency].
    Dahl R; Hilberg O; Løkke A; Pedersen L; Ringbæk T; Titlestad I
    Ugeskr Laeger; 2011 Oct; 173(42):2645-7. PubMed ID: 22027165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional status and muscle strength in patients with emphysema and severe alpha(1)-antitrypsin deficiency.
    Piitulainen E; Areberg J; Lindén M; Eriksson S; Mattsson S; Wollmer P
    Chest; 2002 Oct; 122(4):1240-6. PubMed ID: 12377848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.